Here's another conversation i had with Rik last night. Take out of it whatever, but i feel that progress is being made and this will be a winner for the patient people. I don't think the OTC is made up of a lot of patient investors. Most would prefer for Rik to put out a bunch of BS PR just to get the stock to move for a few ticks so they can sell for a few bucks more than they bought in at. I think time will show that this is a real company that may have fallen on their face a few times, but has learned from their mistakes and will prosper as things move forward. Rik has made mistakes in the past and he has owned up to them, I mean who hasn't made mistakes? In my opinion who either jump on and have faith or just move along (I can respect both options). No logical reason to hang around just to bash a stock.
Me:
MON 9:18PM
Rik, you know Nyloxin is an excellent product. I’ve used it religiously for my shoulders while working out and I’ve tweeked my back the other day, which has happen often over the last 10 years. Usually I would go to the doctor and get some vicodin for use until my back gets better. The Vicodin would help, but of course it has its side effects and the doc is reluctant to prescrib. So Friday I ordered the oral Nyloxin and it came in today. Man this stuff is really amazing, I took the first dose then waited about 15 minutes and then went and pit in a 60 minute workout with zero pain. I just don’t understand how we can’t get this product to be the “go to” medicine for most chronic pain. This stuff should be flying off the shelf considering the opiate crisis going on. It can’t be the price, I would think people with chronic pain will pay whatever for a product that really works. I think people just are not educated or just don’t know that this stuff is out there. What are your ideas to get the word out? I’m not just a shareholder, but a client also...lol...that’s from the “Hair Club for Men” commercial.
Nutrapharma:
It’s all about marketing. The team that’s coming in will make our products a household name.
Me:
Is the new marketing the real deal or, no offense meant, some low cost company, like we’ve seemed to have in the past, that never lived up to expectations?
Nutrapharma:
5:14AM
It’s the strategic investor group.
Nothing cheap. Controlled spending with a buildup as sales ramp up.
Me:
8:01AM
That’s great. Is it possible to put out a PR so the share holders know that the company is going in the right direction?
AI
